There certainly is something to be said for the ingenuity of the American military, particularly during times of great duress and danger.
With the world still battling the COVID-19 pandemic and its wide range of nonstop variants, there are concerns over what medical measures will remain effective as the virus continues to evolve.
This is where the US military comes in.
The U.S. Army has developed a vaccine it says may provide protection against all COVID-19 variants.
The Walter Reed Army Institute of Research (WRAIR) developed a 24-sided object to which it attached various protein spikes from coronavirus variants. The vaccine has completed phase 1 trials, but researchers have yet to test it against the omicron variant, an Army spokesman told Fox News.Trending:
Researchers received a sample in early 2020 and focused efforts on developing a vaccine that would work against potential variants. Two years later, the initial results show promise.
So, how does it work?
The phase 1 human trials commenced April 2021. Scientists hailed the early data as encouraging and will publish final phase 1 study results once they complete the analysis.
The theory behind the development of the Spike Ferritin Nanoparticle Platform (SpFN) vaccine posits that introducing multiple copies of spike proteins in an “ordered fashion” may prove key to creating a “potent and broad response.”
“This vaccine stands out in the COVID-19 vaccine landscape,” said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Brance at WRAIR. “The repetitive and ordered display of the coronavirus spike protein on a multi-faced nanoparticle may stimulate immunity in such a way as to translate into significantly broader protection.”
The news will certainly be given a warm welcome in the United States, where officials are continuing to try to tamp down Christmas gatherings on account of their fears of a resurgence in the pandemic as Americans gather for the holidays.